Plain-English translation of NCT07514754 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a specialized nutrition formula called a galenic immunonutrition formula can help patients with head and neck, lung, or rectal cancer better tolerate their cancer treatments. You would take this formula twice daily during your standard cancer treatment for up to 45 days, along with regular nutritional counseling and your usual cancer care. Researchers want to see if this extra nutritional support reduces treatment side effects and helps maintain your muscle strength and overall health.
Cancer treatments like chemotherapy and radiation can cause severe side effects, poor appetite, and loss of muscle mass that make it harder to complete treatment. This study aims to discover whether giving patients specialized nutritional support during treatment can reduce these complications and help them stay stronger throughout their cancer care.
You likely qualify if…
You likely don't qualify if…
You would take the specialized nutrition formula twice daily starting on your first day of cancer treatment and continuing for up to 45 days. During this time, you would also receive standard nutritional counseling and your regular cancer care as usual. Researchers would monitor your side effects, nutritional status, muscle strength, quality of life, and physical activity through visits and tests to see how well the formula is helping you.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
Italy